Related Experiment Video
Updated: May 5, 2026

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
Published on: February 27, 2018
Anesthesia/surgery activate MMP9 leading to blood-brain barrier disruption, triggering neuroinflammation and POD-like
Yun Hu1, Xu-Dong Hu1, Zi-Qing He1
1Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, PR China.
Abstract:
Anesthesia and surgery activate matrix metalloproteinase 9 (MMP9), leading to blood-brain barrier (BBB) disruption and postoperative delirium (POD)-like behavior, especially in the elderly. Aged mice received intraperitoneal injections of either the MMP9 inhibitor SB-3CT, melatonin, or solvent, and underwent laparotomy under 3 % sevoflurane anesthesia(anesthesia/surgery). Behavioral tests were performed 24 h pre- and post-operatively. Serum and cortical tissue levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) were measured using ELISA. Levels of PDGFRβ, MMP9, tight junction, Mfsd2a, caveolin-1, synaptophysin, and postsynaptic densin (PSD)-95 proteins in the prefrontal cortex were assayed using Western blotting. BBB permeability was assessed by detecting IgG in the prefrontal cortex and serum S100β levels. Anesthesia/surgery-induced peripheral inflammation activated MMP9, which in turn injured pericytes and tight junctions and increased transcytosis, thereby disrupting the BBB. Impaired BBB allowed the migration of peripheral inflammation into the central nervous system (CNS), thereby inducing neuroinflammation, synaptic dysfunction, and POD-like behaviors. However, MMP9 inhibition reduced pericyte and tight junction injury and transcytosis, thereby preserving BBB function and preventing the migration of peripheral inflammation into the CNS, thus attenuating synaptic dysfunction and POD-like behavior. In addition, to further validate the above findings, we showed that melatonin exerted similar effects through inhibition of MMP9. The present study shows that after anesthesia/surgery, inflammatory cytokines upregulation is involved in regulating BBB permeability in aged mice through activation of MMP9, suggesting that MMP9 may be a potential target for the prevention of POD.
Insights
Anesthesia and surgery activate matrix metalloproteinase 9 (MMP9), disrupting the blood-brain barrier (BBB) and causing delirium-like behavior in aged mice. Inhibiting MMP9 or using melatonin preserved BBB function and reduced these effects.
Area of Science:
- Neuroscience
- Immunology
- Gerontology
Background:
- Anesthesia and surgery can trigger matrix metalloproteinase 9 (MMP9) activation.
- This activation is linked to blood-brain barrier (BBB) disruption and postoperative delirium (POD)-like behaviors, particularly in elderly individuals.
- Peripheral inflammation plays a role in this process.
Purpose of the Study:
- To investigate the role of MMP9 in anesthesia/surgery-induced BBB disruption and POD-like behavior in aged mice.
- To evaluate the therapeutic potential of MMP9 inhibition and melatonin in preventing these adverse effects.
Main Methods:
- Aged mice underwent anesthesia/surgery (laparotomy under sevoflurane).
- Mice were treated with an MMP9 inhibitor (SB-3CT) or melatonin.
- Behavioral tests, ELISA for inflammatory cytokines (IL-1β, IL-6, TNF-α), Western blotting for proteins (PDGFRβ, MMP9, tight junctions, etc.), and BBB permeability assays (IgG, S100β) were performed.
Main Results:
- Anesthesia/surgery increased MMP9, leading to BBB disruption via pericyte and tight junction injury and increased transcytosis.
- This BBB impairment facilitated peripheral inflammation entry into the CNS, causing neuroinflammation, synaptic dysfunction, and POD-like behaviors.
- MMP9 inhibition (SB-3CT) or melatonin treatment attenuated these effects by preserving BBB integrity.
Conclusions:
- MMP9 activation by anesthesia/surgery contributes to BBB disruption and POD-like behaviors in aged mice.
- MMP9 inhibition is a potential therapeutic strategy for preventing POD.
- Melatonin may offer similar protective effects through MMP9 inhibition.

